EUCTR2006-001783-23-AT进行中（未招募）不适用
A randomized, double-masked, placebo-controlled two cross-over study comparing the effects of moxaverine and placebo on ocular blood flow
RSAPHARM Arzneimittel GmbH & Co. KG0 个研究点目标入组 16 人开始时间: 2006年7月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •healthy persons
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Symptoms of any systemic disease, abuse of medications, beverages or drugs
研究者
相似试验
已完成
2 期
A study of DE-127 ophthalmic solution in subjects with myopia - A Phase II/IIIMyopiaJPRN-jRCT2080224816Santen Pharmaceutical co.,Ltd288
进行中（未招募）
1 期
Efficacy of gevokizumab in the treatment of patients with Behçet's disease uveitisEUCTR2012-001125-27-GBInstitut de Recherches Internationales Servier84
进行中（未招募）
不适用
Efficacy of gevokizumab in the treatment of patients with Behçet's disease uveitisEUCTR2012-001125-27-GRInstitut de Recherches Internationales Servier110
进行中（未招募）
不适用
Efficacy of gevokizumab in the treatment of patients with Behçet's disease uveitisBehçet?s disease uveitisMedDRA version: 14.1Level: LLTClassification code 10071139Term: Behcet's uveitisSystem Organ Class: 100000004870EUCTR2012-001125-27-ESaboratorios Servier S.L.110
进行中（未招募）
1 期
Efficacy of gevokizumab in the treatment of patients with Behçet's disease uveitisBehçet’s disease uveitisMedDRA version: 18.0Level: LLTClassification code 10071139Term: Behcet's uveitisSystem Organ Class: 100000004866EUCTR2012-001125-27-PTInstitut de Recherches Internationales Servier44